ETPharma Latest news
FDA official sees more vaccine scrutiny in Trump's presidency | Widely used asthma drug impacts brain | GSK's RSV vaccine gets Japan approval
Unsubscribe   |   Report this Email
ETPharma Newsletter | Saturday, November 23, 2024

Daily Newsletter
Top Stories
Top FDA official sees more vaccine scrutiny in Trump's presidency
US FDA finds widely used asthma drug impacts the brain
GSK's RSV vaccine gets Japan approval for adults aged 50 to 59
Pharma Industry
How India Can Catch the Next Wave of Growth in Biosimilars, Biologics, and Vaccines
Sanofi plans to change hospital drug-discount program
Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says
Policy & Regulations
Himachal: HC disposes of spurious drug complaint, orders authority to investigate
Mergers & Acquisitions
Viatris fined in Morocco over merger notification, sources say
Research & Development
Combination drugs more effective in BP treatment, says study
Follow Us on
Copyright © 2024 ETPharma, All rights reserved.
You are receiving this email because you signed up at etpharma.com
Our mailing address is: ETPharma.com (Times Center), FC6, Sector 16 A, Film City, Noida - 201301 Uttar Pradesh, India
Add newsletter@etpharma.com to your address book   |   Our archives are at ETPharma
Unsubscribe   |   Report this Email
Relay Logo

Forwarded to: wystarczy@pxdmail.net.
Stop email forwarding and manage settings for all aliases here.
Sender: newsletter@etpharma.com
This banner is only visible to you. You can turn if off in a Settings.

Options